About MABG
MABG Consulting Group was founded to bridge a critical gap in the industry: transformative technology in diagnostics that never reaches the people who need it most — not because the science isn't ready, but because the strategic path is missing.
The science is ready. The market is waiting.
— Our Story
Built to close the gap between innovation and impact.
MABG brings together deep commercial, technical, and strategic expertise across the in vitro diagnostics (IVD), immunoassay, clinical chemistry, and molecular diagnostics markets.
Co-founded by seasoned industry leaders, the firm combines 20+ years of experience with a proven track record of scaling businesses from early-stage through commercial maturity, driving sustainable revenue growth, and building high-performing organizations aligned to long-term strategic goals.
We are a specialized advisory group dedicated to helping IVD and biotech companies unlock the full commercial potential of their scientific innovations — navigating the complex journey from concept through commercialization.
What Sets Us Apart
A hands-on approach — strategic vision paired with real-world execution.
Bench-grade rigor
Ph.D.-level scientific fluency across qPCR, NGS, immunoassay, and clinical chemistry.
Boardroom fluency
Multinational P&L leadership and multi-year commercial roadmaps.
Hands-on execution
We don't hand off decks. We stay through commercialization.
Measured outcomes
Double-digit growth, funding secured, portfolios launched.
Meet Our Founders
Mike Garofalo
Co-Founder & Chief Executive Officer
Mike Garofalo is a strategic commercial leader with 15+ years of experience driving transformational growth in diagnostics and life science. His career has been defined by one core ability: turning scientific innovation into sustainable revenue.
Most recently serving as North American Sales Director at Medix Biochemica, Mike scaled the regional commercial operation from $8M to $30M+ in revenue; building the sales organization, architecting the go-to-market strategy, and managing a portfolio spanning immunoassay, clinical chemistry, molecular diagnostics, and biological raw materials. He has led commercial operations across every major channel model, including direct sales, distribution, OEM, and strategic partnerships, and has managed some of the largest global accounts in the IVD space.
Before Medix, Mike spent nearly eight years at Enzo Life Sciences, leading North and South American commercial channels and global OEM partnerships totaling $17M in annual revenue.
Mike founded MABG Consulting Group because he saw a gap that kept repeating itself, brilliant science, unclear path to market. He built MABG to close that gap, bringing the commercial rigor, industry relationships, and hands-on execution that growth-stage life science companies need to compete and win.
B.S., Cell and Molecular Biology & Genetics — University of Maryland, College Park
Meet Our Founders
Mike Garofalo
Co-Founder & Chief Executive Officer
Arielle Bryan is a rare force in the life science industry, a Ph.D. molecular geneticist who speaks the language of commercial strategy as fluently as the language of science. With 18+ years of scientific expertise and 6+ years of market development and commercial leadership experience, she specializes in a genuine, deep understanding of the science behind the product and the strategy required to bring it to market.
Her career spans the full translational arc: from conducting high-impact immunology research at Stony Brook Medicine (cited 600+ times) to driving North American market development for Medix Biochemica. At inGenious Targeting Laboratory, she led the commercialization of a novel antibody platform, securing millions in NIH Phase II SBIR funding.
Her technical expertise spans qPCR, RT-qPCR, NGS, isothermal amplification, immunology, oncology, and infectious disease which enables her to align R&D with the "voice of the customer" at top-tier diagnostic manufacturers. At MABG, she serves as the bridge between the bench and the boardroom, ensuring that every commercial strategy is grounded in scientific credibility and market reality.
Ph.D., Molecular Genetics & Microbiology — Stony Brook University
B.S., Biology (Molecular Biology & Genetics, Research Honors) — Macaulay Honors College, City College of New York